文献速递造血干细胞移植与细胞治疗

异基因造血干细胞移植后病毒性脑炎的临床特征与预后模型

Clinical features and prognostic model for viral encephalitis after allogeneic haematopoietic stem cell transplantation.
PubMed 文献 · Br J Haematol · 2024-08-04

该回顾性研究纳入本中心2014至2022年间5380例患者中的211例异基因造血干细胞移植后发生病毒性脑炎者,用Cox回归筛选预后因素并构建GTM模型,内部验证AUC为0.862(95%CI 0.773-0.950),外部AUC为0.815(95%CI 0.708-0.922)。

要点

  • 格拉斯哥昏迷评分<9分、磁共振成像病灶>3个脑叶、重度血小板减少为独立预后危险因素。
  • GTM模型由上述三个危险因素组成,内部验证AUC为0.862(95%CI 0.773-0.950)。
  • 外部验证AUC为0.815(95%CI 0.708-0.922),校准图显示预测与观察结果一致性良好。

核心结论

  • 格拉斯哥昏迷评分<9分、磁共振成像病灶>3个脑叶和重度血小板减少是异基因造血干细胞移植后病毒性脑炎患者的独立预后危险因素。
  • 依据回归系数建立的GTM模型在内部和外部验证中均显示出较强的区分能力,校准图显示预测结局与观察结局一致性良好,决策曲线分析显示该模型具有较高准确性并可能使患者获益。

研究设计与样本

  • 回顾性研究,纳入本中心2014至2022年间5380例患者中211例异基因造血干细胞移植后发生病毒性脑炎的患者。
  • 采用Cox回归分析筛选预后因素并构建预后模型,通过受试者工作特征曲线下面积(AUC)、校准图和决策曲线分析(DCA)进行验证与评估。

主要发现

  • 格拉斯哥昏迷评分<9分、磁共振成像病灶>3个脑叶和重度血小板减少被确定为异基因造血干细胞移植后病毒性脑炎患者的独立预后危险因素。
  • 内部验证AUC为0.862(95%CI 0.773-0.950),外部验证AUC为0.815(95%CI 0.708-0.922)。
  • 校准图显示预测结局与观察结局一致性良好,决策曲线分析显示该模型准确性高并可能使患者获益。

关键数值与推荐

  • GTM模型由三个危险因素组成:格拉斯哥昏迷评分<9分、重度血小板减少(血小板计数<20 000/微升)和磁共振成像病灶>3个脑叶。
  • 内部验证AUC为0.862(95%CI 0.773-0.950),外部验证AUC为0.815(95%CI 0.708-0.922)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The objective of this study was to identify independent prognostic factors of viral encephalitis (VE) after allogeneic haematopoietic stem cell transplantation (allo-HSCT) and establish a prognostic model to identify post-transplant VE patients with a greater likelihood of mortality. Among 5380 patients in our centre from 2014 to 2022, 211 patients who developed VE after allo-HSCT were reviewed in this retrospective study. Prognostic factors were selected, and a prognostic model was constructed using Cox regression analysis. The model was subsequently validated and estimated using the area under the receiver operating characteristic curve (AUC), a calibration plot and decision curve analysis (DCA). Glasgow Coma Scale score <9, lesions >3 lobes on magnetic resonance imaging and severe thrombocytopenia were identified as independent prognostic risk factors for VE patients who underwent allo-HSCT. The prognostic model GTM (GTM is an abbreviation for a model composed of three risk factors: GCS score <9, severe thrombocytopenia [platelet count <20 000 per microliter], and lesions >3 lobes on MRI) was established according to the regression coefficients. The validated internal AUC was 0.862 (95% confidence interval [CI], 0.773-0.950), and the external AUC was 0.815 (95% CI, 0.708-0.922), indicating strong discriminatory ability. Furthermore, we constructed calibration plots that demonstrated good consistency between the predicted outcomes and the observed outcomes. DCA exhibited high accuracy in this system, leading to potential benefits for patients.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Wu J, He YC, Huang QS, et al. Clinical features and prognostic model for viral encephalitis after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2024. PMID: 39099079. doi:10.1111/bjh.19683

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。